Kuo, Shihchen

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., Stein, C., Basit, A., Chan, J. C. N., Mbanya, J. C., et al. (2022) · Diabetes Research and Clinical Practice

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 10,123

Cost-effectiveness of GLP-1 receptor agonists versus insulin for the treatment of type 2 diabetes: a real-world study and systematic review

Yang, C.-Y., Chen, Y.-R., Ou, H.-T., & Kuo, S. (2021) · Cardiovascular Diabetology

Diabetes Treatment and ManagementHealth Systems, Economic Evaluations, Quality of Life

Cited by 51

Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future

Kuo, S., Ou, H.-T., & Wang, C. J. (2021) · Journal of the American Pharmacists Association

Pharmaceutical Economics and PolicySupply Chain Resilience and Risk Management

Cited by 47

Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial

Wexler, D. J., de Boer, I. H., Ghosh, A., Younes, N., Bebu, I., Inzucchi, S. E., McGill, J. B., Mudaliar, S., Schade, D., Steffes, M. W., et al. (2023) · JAMA Internal Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 39

Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis

Chang, K.-C., Shao, S.-C., Kuo, S., Yang, C.-Y., Chen, H.-Y., Chan, Y.-Y., & Ou, H.-T. (2020) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 28

Diabetes care barriers, use, and health outcomes in younger adults with type 1 and type 2 diabetes

Pihoker, C., Braffett, B. H., Songer, T. J., Herman, W. H., Tung, M., Kuo, S., Bellatorre, A., Isganaitis, E., Jensen, E. T., Divers, J., et al. (2023) · JAMA Network Open

Diabetes Management and ResearchDiabetes Management and Education

Cited by 26

Cost-effectiveness of the national diabetes prevention program: a real-world, 2-Year prospective study

Kuo, S., Ye, W., Wang, D., McEwen, L. N., Villatoro Santos, C., & Herman, W. H. (2025) · Diabetes Care

Health Systems, Economic Evaluations, Quality of LifeDiabetes Management and Education

Cited by 19

Cost‐effectiveness of long‐acting insulin analogues vs intermediate/long‐acting human insulin for type 1 diabetes: A population‐based cohort followed over 10 years

Lee, T., Kuo, S., Yang, C., & Ou, H. (2020) · British Journal of Clinical Pharmacology

Diabetes Management and ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 18

Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D

Zgibor, J. C., Kuo, S., Emerson, S., Gittinger, P., Solano, F. X., Tilves, D., Maloney, M., & Davidson, M. B. (2014) · Contemporary Clinical Trials

Diabetes Management and EducationDiabetes Treatment and Management

Cited by 10

Temporal and subgroup disparities in mediation effects on cardiovascular outcomes with liraglutide and semaglutide: a post-hoc analysis of LEADER and SUSTAIN-6 trials

Peng, Z.-Y., Lee, Y.-H., Ou, H.-T., & Kuo, S. (2025) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 5